JP2007501811A - 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用。 - Google Patents
治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用。 Download PDFInfo
- Publication number
- JP2007501811A JP2007501811A JP2006522893A JP2006522893A JP2007501811A JP 2007501811 A JP2007501811 A JP 2007501811A JP 2006522893 A JP2006522893 A JP 2006522893A JP 2006522893 A JP2006522893 A JP 2006522893A JP 2007501811 A JP2007501811 A JP 2007501811A
- Authority
- JP
- Japan
- Prior art keywords
- glycoprotein
- group
- fvii
- ethoxy
- galactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 *C(NCCCON)=O Chemical compound *C(NCCCON)=O 0.000 description 5
- LFMVDJOUAPNLDL-UHFFFAOYSA-N C=[O]C(CCN(CCC(O)=O)C(CON)=O)=O Chemical compound C=[O]C(CCN(CCC(O)=O)C(CON)=O)=O LFMVDJOUAPNLDL-UHFFFAOYSA-N 0.000 description 1
- YAOOTLSBANCHNE-UHFFFAOYSA-N COCCOCCOCC(NCCOCCOCC(COCCOCCNC(COCCOCCOC)=O)OCC(NCCOCCOCC(COCCOCCNC(COC(COCCOCCNC(COCCOCCOC)=O)COCCOCCNC(COCCOCCOC)=O)=O)OCC(NCCC(ON(C(CC1)=O)C1=O)=O)=O)=O)=O Chemical compound COCCOCCOCC(NCCOCCOCC(COCCOCCNC(COCCOCCOC)=O)OCC(NCCOCCOCC(COCCOCCNC(COC(COCCOCCNC(COCCOCCOC)=O)COCCOCCNC(COCCOCCOC)=O)=O)OCC(NCCC(ON(C(CC1)=O)C1=O)=O)=O)=O)=O YAOOTLSBANCHNE-UHFFFAOYSA-N 0.000 description 1
- WGNWWGNWXVWVCD-FLPIEVNYSA-N C[C@H](CC(OC(C)(C)C)=O)C(C)C1[O](CCCCN(C(c2c3cccc2)=O)C3=[O]=C)CC1 Chemical compound C[C@H](CC(OC(C)(C)C)=O)C(C)C1[O](CCCCN(C(c2c3cccc2)=O)C3=[O]=C)CC1 WGNWWGNWXVWVCD-FLPIEVNYSA-N 0.000 description 1
- GNVMDDCBVKDSHZ-UHFFFAOYSA-O C[NH2+]CCOCCOCCOCC(O)=O Chemical compound C[NH2+]CCOCCOCCOCC(O)=O GNVMDDCBVKDSHZ-UHFFFAOYSA-O 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200301145 | 2003-08-08 | ||
| US49444703P | 2003-08-12 | 2003-08-12 | |
| DKPA200301646 | 2003-11-05 | ||
| US51921203P | 2003-11-12 | 2003-11-12 | |
| PCT/DK2004/000530 WO2005014035A2 (en) | 2003-08-08 | 2004-08-09 | Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011051681A Division JP2011157365A (ja) | 2003-08-08 | 2011-03-09 | 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2007501811A true JP2007501811A (ja) | 2007-02-01 |
Family
ID=34139681
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006522893A Withdrawn JP2007501811A (ja) | 2003-08-08 | 2004-08-09 | 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用。 |
| JP2006522894A Pending JP2007501812A (ja) | 2003-08-08 | 2004-08-09 | ペプチドのための結合剤として新しい構造上十分に定義された枝分れしたポリマーの合成および適用 |
| JP2011051681A Withdrawn JP2011157365A (ja) | 2003-08-08 | 2011-03-09 | 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006522894A Pending JP2007501812A (ja) | 2003-08-08 | 2004-08-09 | ペプチドのための結合剤として新しい構造上十分に定義された枝分れしたポリマーの合成および適用 |
| JP2011051681A Withdrawn JP2011157365A (ja) | 2003-08-08 | 2011-03-09 | 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用 |
Country Status (3)
| Country | Link |
|---|---|
| EP (2) | EP1653996A2 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2007501811A (cg-RX-API-DMAC7.html) |
| WO (2) | WO2005014035A2 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8067526B2 (en) | 2009-03-27 | 2011-11-29 | Nof Corporation | Method for producing polyoxalkylene derivative |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7723296B2 (en) | 2001-01-18 | 2010-05-25 | Genzyme Corporation | Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
| DE10209821A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
| WO2004032971A1 (en) | 2002-10-08 | 2004-04-22 | Fresenius Kabi Deutschland Gmbh | Pharmaceutically active oligosaccharide conjugates |
| CA2522345A1 (en) | 2003-04-09 | 2004-11-18 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
| WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
| US20060228331A1 (en) | 2003-10-10 | 2006-10-12 | Novo Nordisk A/S | IL-21 Derivatives and variants |
| DE602004029173D1 (de) * | 2003-10-10 | 2010-10-28 | Novo Nordisk As | Il-21-derivate |
| US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
| CA2565414A1 (en) | 2004-05-04 | 2005-11-24 | Novo Nordisk Health Care Ag | O-linked glycoforms of polypeptides and method to manufacture them |
| WO2006010143A2 (en) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
| EP1814573B1 (en) | 2004-10-29 | 2016-03-09 | ratiopharm GmbH | Remodeling and glycopegylation of fibroblast growth factor (fgf) |
| CA2593682C (en) | 2005-01-10 | 2016-03-22 | Neose Technologies, Inc. | Glycopegylated granulocyte colony stimulating factor |
| US20090036353A1 (en) * | 2005-01-27 | 2009-02-05 | Novo Nordisk A/S | Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers |
| MX2007009906A (es) * | 2005-02-16 | 2007-09-25 | Novo Nordisk As | Derivados de agentes insulinotropicos conjugados con polimeros ramificados estructuralmente bien definidos. |
| JP2008532966A (ja) * | 2005-03-11 | 2008-08-21 | フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 不活性出発物質からの生理活性糖タンパク質の生成 |
| WO2006094826A2 (en) * | 2005-03-11 | 2006-09-14 | Fresenius Kabi Deutschland Gmbh | Method for coupling enzymatically activated glycoconjugates to a hydroxyalkyl starch |
| TWI362392B (en) | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
| ES2484796T3 (es) | 2005-03-18 | 2014-08-12 | Novo Nordisk A/S | Compuestos de GLP-1 extendidos |
| US9187546B2 (en) | 2005-04-08 | 2015-11-17 | Novo Nordisk A/S | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| CA2611823C (en) | 2005-06-16 | 2013-07-30 | Nektar Therapeutics Al, Corporation | Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates |
| US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
| RS51319B (sr) | 2005-09-22 | 2010-12-31 | Biocompatibles Uk Limited | GLP-l (GLUKAGON-LIKE PEPTID-l) FUZIONI POLIPEPTIDI SA POVEĆANOM OTPORNOSTI NA PEPTIDAZE |
| US20090048440A1 (en) | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
| CU23556A1 (es) | 2005-11-30 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Estructura polimérica semejante a dendrímero para la obtención de conjugados de interés farmacéutico |
| WO2007075534A2 (en) | 2005-12-16 | 2007-07-05 | Nektar Therapeutics Al, Corporation | Polymer conjugates of glp-1 |
| EP1854455B1 (en) | 2006-05-10 | 2009-10-07 | Biocompatibles UK Limited | Spherical microcapsules comprising GLP-1 peptides, their production and use |
| US8268948B2 (en) | 2006-07-21 | 2012-09-18 | Nektar Therapeutics | Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom |
| CN101516388B (zh) | 2006-07-21 | 2012-10-31 | 诺和诺德公司 | 通过o-联糖基化序列的肽的糖基化 |
| US20100056428A1 (en) | 2006-09-01 | 2010-03-04 | Novo Nordisk Health Care Ag | Modified proteins |
| US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
| DK2101821T3 (da) | 2006-12-15 | 2014-10-06 | Baxter Healthcare Sa | Faktor VIIA-(poly)sialinsyre-konjugat med forlænget halveringstid in vivo |
| WO2008082613A2 (en) | 2006-12-27 | 2008-07-10 | Nektar Therapeutics Al, Corporation | Factor ix moiety-polymer conjugates having a releasable linkage |
| MX2009007145A (es) | 2006-12-27 | 2009-08-27 | Nektar Therapeutics Al Corp | Conjugados de polimero con factor viii y factor de von willebrand que tienen una ligadura liberable. |
| CN102978185B (zh) | 2007-01-18 | 2015-02-11 | 建新公司 | 包含氨基氧基基团的寡糖及其轭合物 |
| EP2144923B1 (en) | 2007-04-03 | 2013-02-13 | BioGeneriX AG | Methods of treatment using glycopegylated g-csf |
| EP2157967B1 (en) * | 2007-04-23 | 2013-01-16 | Intarcia Therapeutics, Inc | Suspension formulations of insulinotropic peptides and uses thereof |
| WO2008154639A2 (en) | 2007-06-12 | 2008-12-18 | Neose Technologies, Inc. | Improved process for the production of nucleotide sugars |
| US20130189239A1 (en) | 2008-02-27 | 2013-07-25 | Novo Nordisk A/S | Conjugated Factor VIII Molecules |
| WO2010015668A1 (en) | 2008-08-06 | 2010-02-11 | Novo Nordisk A/S | Conjugated proteins with prolonged in vivo efficacy |
| EP3608330B1 (en) | 2008-12-16 | 2022-11-09 | Genzyme Corporation | Synthetic intermediates for preparing oligosaccharide-protein conjugates |
| JP5816097B2 (ja) | 2009-01-22 | 2015-11-18 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | 安定な成長ホルモン化合物 |
| RU2744370C2 (ru) | 2009-07-27 | 2021-03-05 | Баксалта Инкорпорейтед | Конъюгаты белков свертывания крови |
| US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| BR112012001814A8 (pt) | 2009-07-27 | 2018-02-06 | Baxalta GmbH | Conjugados de proteína de coagulação sanguínea |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| EP3081233B1 (en) * | 2009-07-27 | 2020-12-23 | Baxalta GmbH | Glycopolysialylation of proteins other than blood coagulation proteins |
| WO2011015649A1 (en) | 2009-08-06 | 2011-02-10 | Novo Nordisk Health Care Ag | Growth hormones with prolonged in-vivo efficacy |
| EP2507267B1 (en) | 2009-12-02 | 2016-09-14 | Acceleron Pharma, Inc. | Compositions and methods for increasing serum half-life of fc fusion proteins |
| US20120329711A1 (en) * | 2009-12-16 | 2012-12-27 | Nordisk A/S | Glp-1 receptor agonist compounds with a modified n-terminus |
| PL2525834T3 (pl) | 2010-01-22 | 2020-10-19 | Novo Nordisk Health Care Ag | Hormony wzrostu o przedłużonej skuteczności in-vivo |
| RU2012134974A (ru) | 2010-01-22 | 2014-02-27 | Ново Нордиск Хелс Кеа Аг | Стабилизированное соединение гормона роста |
| MX375112B (es) | 2010-07-09 | 2025-03-06 | Biogen Hemophilia Inc | Polipéptidos de factor ix y métodos para usarlos. |
| MX377589B (es) | 2010-12-16 | 2025-03-10 | Novo Nordisk As | Composiciones sólidas que comprenden agonista de glp-1 y sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico. |
| ES2800983T3 (es) | 2010-12-22 | 2021-01-07 | Baxalta GmbH | Materiales y métodos para conjugar un derivado de ácido graso soluble en agua con una proteína |
| US8901341B2 (en) * | 2011-02-11 | 2014-12-02 | Bezwada Biomedical, Llc | Amino acid derivatives and absorbable polymers therefrom |
| AU2012241894B2 (en) | 2011-04-12 | 2015-12-03 | Novo Nordisk A/S | Double-acylated GLP-1 derivatives |
| US8883982B2 (en) | 2011-06-08 | 2014-11-11 | Acceleron Pharma, Inc. | Compositions and methods for increasing serum half-life |
| US9790305B2 (en) * | 2011-09-09 | 2017-10-17 | Franklin And Marshall College | Site specifically incorporated initiator for growth of polymers from proteins |
| KR102072202B1 (ko) | 2012-03-22 | 2020-01-31 | 노보 노르디스크 에이/에스 | Glp-1 펩티드의 조성물 및 그것의 제조 |
| ES2715308T3 (es) | 2012-03-22 | 2019-06-03 | Novo Nordisk As | Composiciones que comprenden un agente de suministro y su preparación |
| WO2013189988A1 (en) | 2012-06-20 | 2013-12-27 | Novo Nordisk A/S | Tablet formulation comprising a peptide and a delivery agent |
| US9790268B2 (en) | 2012-09-12 | 2017-10-17 | Genzyme Corporation | Fc containing polypeptides with altered glycosylation and reduced effector function |
| JP2015533152A (ja) | 2012-10-15 | 2015-11-19 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | 第vii因子コンジュゲート |
| ES2841123T3 (es) | 2013-04-05 | 2021-07-07 | Formulacion Del Compuesto De La Hormona De Crecimiento | Formulación del compuesto de la hormona de crecimiento |
| RS58039B1 (sr) | 2013-05-02 | 2019-02-28 | Novo Nordisk As | Oralno doziranje glp-1 jedinjenja |
| CA2927756A1 (en) | 2013-10-15 | 2015-04-23 | Novo Nordisk Health Care Ag | Coagulation factor vii polypeptides |
| HUE061339T2 (hu) * | 2014-03-19 | 2023-06-28 | Genzyme Corp | Targetáló csoportok helyspecifikus glikotechnikai átalakítása |
| KR20170010003A (ko) * | 2014-05-27 | 2017-01-25 | 아카데미아 시니카 | 박테로이드 기원의 푸코시다제 및 이의 사용 방법 |
| US20180045734A1 (en) * | 2015-03-06 | 2018-02-15 | Tymora Analytical Operations Llc | Chemically functionalized array to analyze protein modifications |
| CN106478806B (zh) * | 2016-10-24 | 2019-08-30 | 合肥国肽生物科技有限公司 | 一种索玛鲁肽的固相合成方法 |
| AR114353A1 (es) | 2018-02-02 | 2020-08-26 | Novo Nordisk As | Composiciones sólidas que comprenden un agonista del glp-1 y una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico |
| MX2023007965A (es) * | 2021-01-04 | 2023-08-14 | Biocon Ltd | Sintesis de teduglutida. |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06506217A (ja) * | 1991-03-18 | 1994-07-14 | エンゾン,インコーポレーテッド | ポリペプチドまたはグリコポリペプチドとポリマーとのヒドラジン含有結合体 |
| WO1994028024A1 (en) * | 1993-06-01 | 1994-12-08 | Enzon, Inc. | Carbohydrate-modified polymer conjugates with erythropoietic activity |
| JPH08508256A (ja) * | 1993-03-23 | 1996-09-03 | シキュウス ファーマシューティカルズ,インコーポレイテッド | 増強循環エフェクター組成物および方法 |
| JPH08510761A (ja) * | 1994-03-07 | 1996-11-12 | ザ・ダウ・ケミカル・カンパニー | 生物活性及び/又はターゲテッドデンドリマー複合体 |
| WO1996036357A1 (en) * | 1995-05-15 | 1996-11-21 | Bona Constantin A | Carbohydrate-mediated coupling of peptides to immunoglobulins |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU583854B2 (en) * | 1984-09-13 | 1989-05-11 | Cytogen Corporation | Antibody therapeutic agent conjugates |
| US6180134B1 (en) * | 1993-03-23 | 2001-01-30 | Sequus Pharmaceuticals, Inc. | Enhanced ciruclation effector composition and method |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| AU720860B2 (en) * | 1996-10-08 | 2000-06-15 | Macquarie Research Limited | Glycan derivatives |
| JP2927291B2 (ja) * | 1997-09-01 | 1999-07-28 | 東洋インキ製造株式会社 | ビニル基含有デンドリマー |
| US6485718B1 (en) * | 1999-04-13 | 2002-11-26 | Pharmacia Corporation | Site specific ligation of proteins to synthetic particles |
| JP2003503591A (ja) * | 1999-06-29 | 2003-01-28 | ダコ エー エス | 標識およびプローブを保持するデンドリマーを用いた検出 |
| WO2001058935A2 (en) * | 2000-02-11 | 2001-08-16 | Maxygen Aps | FACTOR VII OR VIIa-LIKE MOLECULES |
| MXPA03000310A (es) * | 2000-07-12 | 2004-12-13 | Gryphon Therapeutics Inc | Quimiocinas sinteticas bioactivas, modificadas con polimeros y metodos para su elaboracion y uso. |
| AU2002240312A1 (en) * | 2001-02-08 | 2002-08-19 | Pankaj Paranjp | Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates |
| EP1446438A2 (en) * | 2001-11-07 | 2004-08-18 | Nektar Therapeutics Al, Corporation | Branched polymers and their conjugates |
-
2004
- 2004-08-09 WO PCT/DK2004/000530 patent/WO2005014035A2/en not_active Ceased
- 2004-08-09 WO PCT/DK2004/000531 patent/WO2005014049A2/en not_active Ceased
- 2004-08-09 EP EP04739027A patent/EP1653996A2/en not_active Withdrawn
- 2004-08-09 JP JP2006522893A patent/JP2007501811A/ja not_active Withdrawn
- 2004-08-09 JP JP2006522894A patent/JP2007501812A/ja active Pending
- 2004-08-09 EP EP04739028A patent/EP1654004A2/en not_active Withdrawn
-
2011
- 2011-03-09 JP JP2011051681A patent/JP2011157365A/ja not_active Withdrawn
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06506217A (ja) * | 1991-03-18 | 1994-07-14 | エンゾン,インコーポレーテッド | ポリペプチドまたはグリコポリペプチドとポリマーとのヒドラジン含有結合体 |
| JPH08508256A (ja) * | 1993-03-23 | 1996-09-03 | シキュウス ファーマシューティカルズ,インコーポレイテッド | 増強循環エフェクター組成物および方法 |
| WO1994028024A1 (en) * | 1993-06-01 | 1994-12-08 | Enzon, Inc. | Carbohydrate-modified polymer conjugates with erythropoietic activity |
| JPH08510761A (ja) * | 1994-03-07 | 1996-11-12 | ザ・ダウ・ケミカル・カンパニー | 生物活性及び/又はターゲテッドデンドリマー複合体 |
| WO1996036357A1 (en) * | 1995-05-15 | 1996-11-21 | Bona Constantin A | Carbohydrate-mediated coupling of peptides to immunoglobulins |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8067526B2 (en) | 2009-03-27 | 2011-11-29 | Nof Corporation | Method for producing polyoxalkylene derivative |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011157365A (ja) | 2011-08-18 |
| WO2005014035A2 (en) | 2005-02-17 |
| JP2007501812A (ja) | 2007-02-01 |
| WO2005014049A2 (en) | 2005-02-17 |
| EP1654004A2 (en) | 2006-05-10 |
| WO2005014035A3 (en) | 2005-07-28 |
| WO2005014049A3 (en) | 2005-09-01 |
| EP1653996A2 (en) | 2006-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011157365A (ja) | 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用 | |
| US20100028939A1 (en) | Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic Interest | |
| AU2003240439B2 (en) | Pegylated factor VII glycoforms | |
| US8053410B2 (en) | Pegylated factor VII glycoforms | |
| CN103215328B (zh) | 转谷氨酰胺酶介导的肽的接合 | |
| US20080108557A1 (en) | Modified Proteins | |
| CN101557830B (zh) | 具有延长的体内半衰期的因子VIIa-聚唾液酸结合物 | |
| JP5570809B2 (ja) | 修飾タンパク質 | |
| US20090264366A1 (en) | Transglutaminase Mediated Conjugation of Peptides | |
| CN101600448A (zh) | 甘油连接的peg化的糖和糖肽 | |
| TW201305090A (zh) | 用於偶聯水溶性脂肪酸衍生物與蛋白質之材料及方法 | |
| CN101535339B (zh) | 改性糖蛋白 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070426 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100316 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100524 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100531 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100916 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101109 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110309 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110323 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20110502 |